Consideration of differences in drug usage between young-onset and elderly-onset rheumatoid arthritis with target of low disease activity.
Kosuke KumagaiNoriaki OkumuraYasutaka AmanoTakafumi YayamaTomohiro MimuraTsutomu MaedaMitsuhiko KuboKanji MoriRichard Barrett-JolleyShinji ImaiPublished in: Modern rheumatology (2021)
Patients with EORA may be able to achieve LDA with lower drug dosage than those with YORA.